$ACET now at $2.40 or $22M market cap vs $100M Sept cash. Going to be real interesting what RA and Orbimed decide to do here. Outside of Lupus, got some potentially desirable early stage in-vivo CAR-T programs
$ENGN looks like positive news coming next week regarding 12 month data and FDA alignment for BLA. Posted VP of Marketing position for commercial launch:
$LYEL yesterday sold for largest $ gain ever after buying in Oct. Used proceeds to re-buy crushed $ACET at $27M MC, crushed $CATX under $1 and add $NKTX (data this weekend), $PEPG (data likely Monday), and $ENGN (data any moment now). Still holding lotto $BCAB for strategic news
$PEPG presenting Tues Nov 10th at Gugg and Thur Nov 12th at Stifel. Imagine we get data next week, or Monday the 9th. Bodes well they plan on attending post data?